trending Market Intelligence /marketintelligence/en/news-insights/trending/9HSmMXdO1YeIK0fLYNIslA2 content esgSubNav
In This List

Tabula Rasa HealthCare acquires Australian dosing tool software developer

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Tabula Rasa HealthCare acquires Australian dosing tool software developer

Tabula Rasa HealthCare Inc. has acquired Australian privately held software developer DoseMe Pty Ltd., the developer of a dosing tool used by doctors and pharmacists.

DoseMe develops DoseMeRx, a precision dosing tool that aids physicians and pharmacists in determining the right dose for patients' high risk medicines.

Financial details of the transaction were not disclosed in a Jan. 7 press release.

Charles Cornish, CEO of DoseMe, will continue in his current role. However, he will relocate to Tabula Rasa's headquarters in Moorestown, N.J., following the acquisition.

Tabula Rasa is a healthcare technology company that offers services for medication risk management and pharmacy cost management.